Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Melissa J, Schoelwer"'
Autor:
Erin C, Cobry, Lauren G, Kanapka, Eda, Cengiz, Lori, Carria, Laya, Ekhlaspour, Bruce A, Buckingham, Korey K, Hood, Liana J, Hsu, Laurel H, Messer, Melissa J, Schoelwer, Emma, Emory, Katrina J, Ruedy, Roy W, Beck, Raj Paul, Wadwa, Linda, Gonder-Frederick, Deanna, Gabrielson
Publikováno v:
Diabetes Technol Ther
Introduction: Hybrid closed-loop systems increase time-in-range (TIR) and reduce glycemic variability. Person-reported outcomes (PROs) are essential to assess the utility of new devices and their impact on quality of life. This article focuses on the
Autor:
Trang T. Ly, David W. Hansen, Sarah A. MacLeish, Daniel J. DeSalvo, Amy B. Criego, Bruce A. Buckingham, Melissa J. Schoelwer, Lori M. Laffel, Gregory P. Forlenza, Bruce W. Bode, Jennifer L. Sherr
Objective: Very young children with type 1 diabetes often struggle to achieve glycemic targets, putting them at risk of long-term complications and creating an immense management burden for caregivers. We conducted the first evaluation of the Omnipod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a059148f4bdfadbe531ac4ce3d2f75a9
https://doi.org/10.2337/figshare.19763350.v1
https://doi.org/10.2337/figshare.19763350.v1
Autor:
Mark D. DeBoer, Melissa J Schoelwer
Publikováno v:
Current Nutrition Reports. 10:47-57
Here, we provide a review of recent advancements in closed-loop or automated insulin delivery systems commonly referred to as the “artificial pancreas” (AP) for the management of type 1 diabetes (T1D). The use of hybrid closed-loop devices in chi
Publikováno v:
Diabetes Technology & Therapeutics. 24:856-857
Autor:
Thibault Gautier, Sue A. Brown, Mary Clancy-Oliveri, Daniel R. Cherñavvsky, Jessica Robic, Stacey M. Anderson, Marc D. Breton, Mark D. DeBoer, Melissa J Schoelwer, Kelly Carr, Chiara Fabris
Publikováno v:
Diabetes Technology & Therapeutics. 22:594-601
Objective: To assess the safety and efficacy of a simplified initialization for the Tandem t:slim X2 Control-IQ hybrid closed-loop system, using parameters based on total daily insulin (“MyTDI”) in...
Autor:
Melissa J. Schoelwer, Alan D. Rogol
Publikováno v:
The Encyclopedia of Child and Adolescent Development. :1-15
Autor:
Melissa J, Schoelwer, Lauren G, Kanapka, R Paul, Wadwa, Marc D, Breton, Katrina J, Ruedy, Laya, Ekhlaspour, Gregory P, Forlenza, Erin C, Cobry, Laurel H, Messer, Eda, Cengiz, Emily, Jost, Lori, Carria, Emma, Emory, Liana J, Hsu, Stuart A, Weinzimer, Bruce A, Buckingham, Rayhan A, Lal, Mary Clancy, Oliveri, Craig C, Kollman, Betsy B, Dokken, Daniel R, Cherñavvsky, Roy W, Beck, Mark D, DeBoer, Deanna, Gabrielson
Publikováno v:
Diabetes Technol Ther
Background: Studies of closed-loop control (CLC) in patients with type 1 diabetes (T1D) consistently demonstrate improvements in glycemic control as measured by increased time-in-range (TIR) 70–180 mg/dL. However, clinical predictors of TIR in user
Autor:
the iDCL Trial Research Group, Roy W. Beck, Daniel Cherñavvsky, Betsy B. Dokken, Craig Kollman, Mary Oliveri, Bruce A. Buckingham, Mark D. DeBoer, Stuart A. Weinzimer, Liana J. Hsu, Emma Emory, Lori Carria, Emily Jost, Melissa J. Schoelwer, Eda Cengiz, Gregory P. Forlenza, Laya Ekhlaspour, Katrina J. Ruedy, Marc D. Breton, R. Paul Wadwa, Lauren G. Kanapka
Objective: To further evaluate the safety and efficacy of the Control-IQ closed loop control (CLC) system in children with type 1 diabetes. Research Design and Methods: Following a 16-week randomized clinical trial (RCT) comparing CLC with sensor aug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f5edbd08406fd9aaa7a8035cc8b6acc
https://doi.org/10.2337/figshare.13260212.v1
https://doi.org/10.2337/figshare.13260212.v1
Autor:
Gregory P. Forlenza, Liana J Hsu, Emily Boranian, Cari Berget, Bruce A. Buckingham, R. Paul Wadwa, Mark D. DeBoer, Marc D. Breton, Emma Emory, Laya Ekhlaspour, Lisa M. Norlander, Melissa J Schoelwer, Ryan S. Kingman
Publikováno v:
Diabetes Technology & Therapeutics
Background: Glycemic control is particularly challenging for toddlers and preschoolers with type 1 diabetes (T1D), and data on the use of closed-loop systems in this age range are limited. Materials and Methods: We studied use of a modified investiga
Autor:
Linda Gonder-Frederick, Pearl L. Yu, Alessandro Bisio, Daniel R. Cherñavvsky, Heather Bonner, Mark D. DeBoer, Michael Pajewski, Sue A. Brown, Melissa J Schoelwer, Ryan McFadden, Christian A. Wakeman
Publikováno v:
Pediatric diabetesREFERENCES. 22(3)
BACKGROUND Data on the use of Control-IQ, the latest FDA-approved automated insulin delivery (AID) system for people with T1D 6 years of age or older is still scarce, particularly regarding nonglycemic outcomes. Children with T1D and their parents ar